Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Is this a problem? Didn't expect this...but did some dd and.

<< Previous

Bullboard Posts

Next >>

Post by MagaTrumpon May 08, 2018 8:34pm

241 Views

Post# 28001519

Is this a problem? Didn't expect this...but did some dd and.

I thought the 70% drop in SP (share price) was unjustified since I believed it wasn't a true reflection of their sales in the US..BUT after some very easy due dilligence I see that this is apparently NOT the case, the US was most of their revenue, see the screen shot of their presentation. Here's what we need to consider, since the compnay hasn't made any money after liabilities are added in, maybe the US actually WAS their greatest liability, in terms of trade deals, tarrifs, etc...so maybe this was just basically tearing off a badaid very quickly, and then eventually the market will reflect their true potential value? Who knows...any ideas about this company's future???? Cheers! [img]https://